Green Cross Medical Stock Current Valuation

142280 Stock  KRW 3,475  115.00  3.20%   
Valuation analysis of Green Cross Medical helps investors to measure Green Cross' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
3,475
Please note that Green Cross' price fluctuation is very steady at this time. Calculation of the real value of Green Cross Medical is based on 3 months time horizon. Increasing Green Cross' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Green Cross is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Green Stock. However, Green Cross' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  3475.0 Real  3161.55 Hype  3590.0 Naive  3634.84
The real value of Green Stock, also known as its intrinsic value, is the underlying worth of Green Cross Medical Company, which is reflected in its stock price. It is based on Green Cross' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Green Cross' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
3,162
Real Value
3,949
Upside
Estimating the potential upside or downside of Green Cross Medical helps investors to forecast how Green stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Green Cross more accurately as focusing exclusively on Green Cross' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3,6203,7053,790
Details
Hype
Prediction
LowEstimatedHigh
3,5883,5903,592
Details
Naive
Forecast
LowNext ValueHigh
3,6333,6353,637
Details

Green Cross Medical Company Current Valuation Analysis

Green Cross' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Green Cross Current Valuation

    
  272.85 B  
Most of Green Cross' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Green Cross Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Green Cross Medical has a Current Valuation of 272.85 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

Green Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Green Cross' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Green Cross could also be used in its relative valuation, which is a method of valuing Green Cross by comparing valuation metrics of similar companies.
Green Cross is currently under evaluation in current valuation category among its peers.

Green Fundamentals

About Green Cross Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Green Cross Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Green Cross using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Green Cross Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Green Cross

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Green Cross position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Green Cross will appreciate offsetting losses from the drop in the long position's value.

Moving together with Green Stock

  0.68293780 AptaBio TherapeuticsPairCorr

Moving against Green Stock

  0.48041190 Woori Technology InvPairCorr
The ability to find closely correlated positions to Green Cross could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Green Cross when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Green Cross - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Green Cross Medical to buy it.
The correlation of Green Cross is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Green Cross moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Green Cross Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Green Cross can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Green Stock

Green Cross financial ratios help investors to determine whether Green Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Green with respect to the benefits of owning Green Cross security.